"This technology gives us a powerful tool to detect prostate cancer earlier and more precisely,” said Dr. James Howard.

An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

CURE highlights prostate cancer advancements from Day One of the 2026 ASCO Genitourinary Cancers Symposium.

The new drug, known as VIR-5500, uses a so-called cloaking device and only activates when it reaches the tumour ...

Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.

Patients with a type of prostate cancer known as metastatic castration-sensitive prostate cancer (mCSPC), who have specific genetic mutations, were found to have improved survival by using a targeted ...

News, features, and commentary about cancer-related issues ...

From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...

Prostate cancer is the most common cancer in men throughout the United States. Most men do not realize they have cancer due ...

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...